UK markets open in 3 hours 49 minutes
NIKKEI 225
38,199.10 +19.64 (+0.05%) HANG SENG
19,131.24 +16.18 (+0.08%) CRUDE OIL
79.15 +0.03 (+0.04%) GOLD FUTURES
2,346.50 +3.50 (+0.15%) DOW
39,431.51 -81.29 (-0.21%) Bitcoin GBP
49,714.00 +1,150.00 (+2.37%)
Orchestra BioMed Holdings, Inc. (OBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 164.62M |
| Enterprise value | 78.71M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 55.38 |
| Price/book (mrq) | 2.42 |
| Enterprise value/revenue | 2.73k |
| Enterprise value/EBITDA | -15.53 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.22 |
| 52-week change 3 | -72.86% |
| S&P500 52-week change 3 | 27.04% |
| 52-week high 3 | 20.1900 |
| 52-week low 3 | 4.2200 |
| 50-day moving average 3 | 5.1362 |
| 200-day moving average 3 | 6.4462 |
Share statistics
| Avg vol (3-month) 3 | 41.56k |
| Avg vol (10-day) 3 | 34.96k |
| Shares outstanding 5 | 35.79M |
| Implied shares outstanding 6 | 35.79M |
| Float 8 | 19.46M |
| % held by insiders 1 | 32.16% |
| % held by institutions 1 | 42.01% |
| Shares short (30 Apr 2024) 4 | 856.26k |
| Short ratio (30 Apr 2024) 4 | 24 |
| Short % of float (30 Apr 2024) 4 | 4.47% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.39% |
| Shares short (prior month 28 Mar 2024) 4 | 858.02k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -4,763.74% |
Management effectiveness
| Return on assets (ttm) | -33.75% |
| Return on equity (ttm) | -81.47% |
Income statement
| Revenue (ttm) | 2.76M |
| Revenue per share (ttm) | 0.08 |
| Quarterly revenue growth (yoy) | -76.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -51.22M |
| Net income avi to common (ttm) | -49.12M |
| Diluted EPS (ttm) | -1.4800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 87.59M |
| Total cash per share (mrq) | 2.45 |
| Total debt (mrq) | 1.69M |
| Total debt/equity (mrq) | 2.48% |
| Current ratio (mrq) | 7.95 |
| Book value per share (mrq) | 1.90 |
Cash flow statement
| Operating cash flow (ttm) | -46.13M |
| Levered free cash flow (ttm) | -32.17M |
© 2024 Yahoo. All rights reserved.